Precipio (PRPO) Stock Chart & Stock Price History → **Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (From Huge Alerts) (Ad) Free PRPO Stock Alerts $6.00 -0.29 (-4.61%) (As of 12:45 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Precipio Stock Price Performance5 Day Performance-3.85%1 Month Performance-3.23%3 Month Performance-5.51%6 Month Performance-15.85%Year-To-Date Performance-7.69%1 Year Performance-52.72% Receive PRPO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Precipio and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry ResearchEverybody laughed when he recommended Netflix"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. PRPO Stock Chart for Monday, May, 20, 2024 PRPO Chart by TradingView Precipio Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$6.21$6.29+1.29%$6.50$5.9814,773 shs$9.25 million05/16/2024$6.24$6.21-0.48%$6.48$5.955,768 shs$9.13 million05/15/2024$6.49$6.24-3.85%$6.49$6.241,658 shs$9.17 million05/14/2024$6.28$6.49+3.34%$6.49$6.282,697 shs$9.54 million05/13/2024$6.04$6.28+4.06%$6.30$6.032,014 shs$9.23 million05/10/2024$5.77$6.05+4.78%$6.29$5.837,988 shs$8.89 million Get the Latest News and Ratings for PRPO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Precipio and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$5.68$5.77+1.65%$6.19$5.7114,452 shs$8.48 million05/08/2024$5.68$5.68$5.68$5.68276 shs$8.34 million05/07/2024$5.98$5.68-4.99%$6.02$5.683,723 shs$8.35 million05/06/2024$5.80$5.98+3.07%$5.98$5.781,261 shs$8.79 million05/03/2024$5.95$5.80-2.53%$6.00$5.75917 shs$8.52 million05/02/2024$5.62$5.95+5.88%$5.95$5.654,551 shs$8.75 million05/01/2024$5.75$5.62-2.26%$5.70$5.621,462 shs$8.04 million04/30/2024$5.90$5.75-2.54%$6.08$5.616,609 shs$8.22 million04/29/2024$6.03$5.90-2.07%$6.02$5.902,763 shs$8.44 million04/26/2024$6.18$6.03-2.43%$6.21$5.809,309 shs$8.62 million04/25/2024$5.86$6.18+5.38%$6.30$5.718,112 shs$8.83 million04/24/2024$6.15$5.86-4.72%$6.17$5.807,022 shs$8.38 million04/23/2024$6.33$6.15-2.84%$6.29$6.063,618 shs$8.79 million04/22/2024$6.20$6.33+2.10%$6.33$6.33515 shs$9.05 million04/19/2024$6.71$6.20-7.53%$6.67$6.201,663 shs$8.87 million04/18/2024$6.71$6.71$6.71$6.71214 shs$9.59 million04/17/2024$6.73$6.71-0.37%$6.71$6.62815 shs$9.59 million04/16/2024$6.74$6.73-0.08%$6.75$6.73284 shs$9.62 million04/15/2024$6.65$6.74+1.22%$6.78$6.611,653 shs$9.63 million04/12/2024$6.65$6.70+0.78%$6.84$6.653,352 shs$9.58 million04/11/2024$6.65$6.65$6.65$6.65438 shs$9.51 million04/10/2024$6.35$6.65+4.69%$6.81$6.358,532 shs$9.51 million04/09/2024$6.51$6.35-2.46%$6.48$6.1524,256 shs$9.08 million04/08/2024$6.32$6.51+3.01%$6.51$6.181,008 shs$9.31 million04/05/2024$6.32$6.32$6.32$6.15863 shs$9.04 million04/04/2024$6.32$6.32+0.08%$6.34$6.104,700 shs$9.04 million04/03/2024$6.48$6.32-2.55%$6.48$6.32663 shs$9.03 million04/02/2024$6.84$6.48-5.26%$6.87$6.166,103 shs$9.20 million04/01/2024$6.70$6.84+2.09%$7.00$6.4514,617 shs$9.71 million03/29/2024$6.70$6.70$6.70$6.0110,183 shs$9.51 million03/28/2024$6.20$6.70+8.00%$6.70$6.0110,183 shs$9.51 million03/27/2024$6.08$6.20+1.97%$6.24$6.003,333 shs$8.81 million03/26/2024$6.00$6.08+1.40%$6.08$6.00629 shs$8.64 million03/25/2024$6.02$6.00-0.33%$6.35$6.002,809 shs$8.52 millionMust-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story…03/22/2024$6.02$6.20+2.99%$6.26$6.002,353 shs$8.80 million03/21/2024$6.02$6.02$6.02$6.02201 shs$8.55 million03/20/2024$6.25$6.02-3.68%$6.02$6.00588 shs$8.55 million03/19/2024$6.19$6.25+0.97%$6.25$6.231,197 shs$8.88 million03/18/2024$6.10$6.19+1.48%$6.47$6.102,350 shs$8.79 million03/15/2024$6.04$6.10+0.99%$6.48$6.102,790 shs$8.66 million03/14/2024$6.20$6.04-2.58%$6.26$6.00791 shs$8.58 million03/13/2024$6.33$6.20-2.05%$6.32$6.003,166 shs$8.80 million03/12/2024$6.25$6.33+1.28%$6.51$6.331,653 shs$8.99 million03/11/2024$6.21$6.25+0.64%$6.44$6.113,161 shs$8.88 million03/08/2024$6.10$6.38+4.59%$6.44$6.021,081 shs$9.06 million03/07/2024$6.42$6.10-4.98%$6.30$6.101,370 shs$8.66 million03/06/2024$6.36$6.42+0.91%$6.42$6.36812 shs$9.12 million03/05/2024$6.43$6.36-1.06%$6.46$6.046,254 shs$9.03 million03/04/2024$6.50$6.43-1.08%$6.66$6.224,352 shs$9.13 million03/01/2024$6.50$6.50$6.64$6.3810,148 shs$9.23 million02/29/2024$6.66$6.50-2.40%$6.66$6.421,490 shs$9.23 million02/28/2024$6.50$6.66+2.46%$6.69$6.302,936 shs$9.46 million02/27/2024$6.41$6.50+1.40%$6.50$6.363,414 shs$9.23 million02/26/2024$6.21$6.41+3.22%$6.41$6.241,159 shs$9.10 million02/23/2024$6.38$6.21-2.66%$6.21$6.21288 shs$8.82 million02/22/2024$6.35$6.38+0.47%$6.38$6.01471 shs$9.06 million02/21/2024$6.35$6.35$6.37$6.35492 shs$9.02 million02/20/2024$6.58$6.35-3.50%$6.52$6.201,640 shs$9.02 million02/19/2024$6.58$6.58$6.73$6.581,200 shs$9.34 million Related Companies: Telesis Bio Stock Price Chart Talis Biomedical Stock Price Chart Accelerate Diagnostics Stock Price Chart Cue Health Stock Price Chart Singular Genomics Systems Stock Price Chart Rapid Micro Biosystems Stock Price Chart Galera Therapeutics Stock Price Chart IM Cannabis Stock Price Chart Universe Pharmaceuticals Stock Price Chart Chemomab Therapeutics Stock Price Chart Receive PRPO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Precipio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PRPO) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precipio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.